ITAMI 140 MG MEDICATED PATCH 5 PATCHES

Name
Itami 140 mg Medicated plaster
Diclofenac sodium
Equivalent medicine


What it is and what it is used for
Itami contains the active substance diclofenac and belongs to a group of medicines called 'non-steroidal anti-inflammatory drugs' (NSAIDs).

Itami is indicated for the local treatment of pain and inflammation of a rheumatic nature or resulting from trauma to the joints, muscles, tendons and ligaments.

Talk to your doctor if you do not feel better or if you feel worse after 14 days.


What you need to know before taking the medicine
Do not use Itami if:
- are allergic to diclofenac or any of the other ingredients of this medicine listed in section 6;
- are allergic to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs;
- following the intake of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) you have experienced allergic reactions which have presented themselves with difficulty in breathing (asthma attacks), inflammation of the nasal mucosa (rhinitis), sudden appearance of a more or less itchy skin rash (urticaria);
- has damaged skin due to: inflammation of the skin with blistering (exudative dermatitis), eczema, infected lesion, burns or wounds;
- you are in the third trimester of pregnancy (see section " Pregnancy, breast-feeding and fertility ");
- has lesions in the stomach or intestine (active peptic ulcer).

Itami should not be used in children and adolescents under 16 years of age.


Warnings and precautions
Talk to your doctor or pharmacist before using Itami.

Stop treatment with Itami immediately and consult your doctor if:
- obvious appearance of a skin rash after applying the patch.

Pay special attention:
- if you are taking other NSAIDs or other medicines containing diclofenac, including topical medicines;
- if you have kidney, heart or liver problems, have had a peptic ulcer, inflammatory bowel disease or are prone to developing bleeding;
- if you are elderly, as you are subject to an increased frequency of side effects;
- if you have had an allergic reaction in the past after taking NSAIDs or painkillers, since asthmatic patients with chronic obstructive bronchial diseases, inflammation of the nasal mucosa (allergic rhinitis), nasal polyps develop asthma attacks, local inflammation of the skin or mucosa (Quincke's edema) or urticaria more often than other patients;
- if you intend to become pregnant, have fertility problems or need to undergo fertility tests; treatment with Itami should be stopped;
- if you use Itami on large areas of skin or for a prolonged period as you may develop the appearance of side effects that affect the whole body (systemic);
- the patches must not come into contact with the eyes, mucous membranes and must not be ingested;
- if you need to expose yourself to direct sunlight or sunlamps; wait at least one day after removing the patch to reduce the risk of sensitivity to light.

The undesirable effects of NSAIDs can be minimised by using the lowest effective dose and by using the shortest duration possible to control symptoms.

Children and adolescents
Itami should not be used in children and adolescents under 16 years of age.


Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

Using Itami at the same time as other diclofenac-based medicines may cause serious skin diseases with blistering, redness and peeling (Steven-Johnson syndrome) or diseases leading to skin necrosis (Lyell syndrome).

Common side effects (may affect up to 1 in 10 people):
- rash, eczema, erythema, dermatitis (including allergic dermatitis and contact dermatitis), pruritus, reactions at the site of patch application.

Rare side effects (may affect up to 1 in 1,000 people):
- bullous dermatitis;
- dry skin.

Very rare side effects (may affect up to 1 in 10,000 people):
- allergic reaction (hypersensitivity) including hives, anaphylactoid reaction, swelling of the face, hands and feet, lips, tongue, throat and/or larynx (angioneurotic oedema);
- skin rash with the appearance of vesicles;
- asthma;
- sensitivity to light (photosensitivity).

Unknown side effects:
- burning sensation at the application site.

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.